High Note Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
High Note Wealth's ALNY Position: Q2 2026 in Review
High Note Wealth increased its Alnylam Pharmaceuticals (ALNY) stake by 300% in Q2 2026, buying an estimated $2.71K and bringing the position to 12 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #703.
High Note Wealth first reported a position in ALNY in Q4 2025 and has held it in 3 quarters since. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- High Note Wealth held 12 shares of Alnylam Pharmaceuticals worth $3.61K as of Q2 2026.
- High Note Wealth bought 9 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.71K.
- Alnylam Pharmaceuticals made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #703 holding.
- High Note Wealth first reported a position in Alnylam Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.